HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MONOCLONAL ANTIBODY, SIBEPRENLIMAB, IN PATIENTS WITH IgA NEPHROPATHY IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL

  Back

14 Apr 2024 5:45 p.m. 6:45 p.m.

WCN24-AB-1799, Poster Board= SUN-019

Jonathan Barratt Poster Presenter